Nicholas C Dracopoli

Title: Innovations in Cancer Treatment by Nicholas C Dracopoli

Introduction

Nicholas C Dracopoli is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on improving the prediction of responses in cancer patients treated with immunotherapy.

Latest Patents

Dracopoli holds a patent for a method that enhances the prediction of therapeutic responses in cancer patients. The patent, titled "Method of improving prediction of response for cancer patients treated with immunotherapy," outlines a process for determining a therapeutic regimen based on tumor mutation burden (TMB) and loss of heterozygosity (LOH). The method indicates that high TMB combined with no LOH suggests a positive outcome when treated with a checkpoint inhibitor, while high TMB with LOH indicates a poor outcome. This innovative approach has the potential to significantly impact treatment strategies for cancer patients.

Career Highlights

Nicholas C Dracopoli is associated with Personal Genome Diagnostics, Inc., where he continues to advance research in genomics and cancer treatment. His expertise in the field has led to valuable insights that contribute to personalized medicine.

Collaborations

Dracopoli collaborates with various professionals in the field, including his coworker Gustavo Cerqueira. Their combined efforts aim to enhance the understanding and treatment of cancer through innovative research.

Conclusion

Nicholas C Dracopoli's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer treatment. His patented methods provide a promising avenue for improving patient outcomes and advancing personalized medicine.